What does Vaxcyte, Inc. do?
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive…
What is Vaxcyte, Inc.'s P/E and P/B ratio?
Vaxcyte, Inc. has a P/E ratio of -8.2 and a P/B ratio of 3.59.
What is Vaxcyte, Inc.'s debt-to-equity ratio?
Vaxcyte, Inc. has a debt-to-equity ratio of 0.04.
How much does Vaxcyte, Inc. owe compared with what it owns?
Vaxcyte, Inc. owes $0.12 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Vaxcyte, Inc.'s Positivity rank?
Vaxcyte, Inc. is ranked #4,962 of 6,775 companies globally and #2,601 of 4,000 in United States on PositoAI, with a Positivity Score of 18,713.
Does Vaxcyte, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Vaxcyte, Inc..
Where can I read the latest news about Vaxcyte, Inc.?
Recent headlines about Vaxcyte, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Vaxcyte, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Vaxcyte, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.